Premaitha Health Plc (LON:NIPT) uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA® uses complex statistical analysis to determine the likelihood that a fetus is

Premaitha Health Plc (LON:NIPT) uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA estimates the risk that a fetus has any of Down’s, Edwards’ or

Premaitha Health Plc (LON:NIPT) is a molecular diagnostics company that has used the latest advances in DNA technology to develop a non-invasive pre-natal screening test. IONA is its first test,